Skip to main content

RachelKobosMD

Pediatric Hematology & Oncology • New York, NY

Physician

Request Appointment

Overview of Dr. Kobos

Dr. Rachel Kobos is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and New York-Presbyterian Hospital. She received her medical degree from New York Medical College and has been in practice 15 years. Dr. Kobos accepts several types of health insurance, listed below. She is one of 92 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She has more than 40 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2002 - 2005
  • New York Medical College
    New York Medical CollegeClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2026
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in First Relapse Patients (pts) with Multiple Myeloma...
    Rachel Kobos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Four-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed ...
    Rachel Kobos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Effectiveness of Daratumumab in Combination with Lenalidomide and Dexamethasone (DRd) Vs. Common Standard-of-Care Regimens in Patients with Non-Transplant Newly Diagno...
    Rachel Kobos, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Lectures

  • Clofarabine with Topotecan, Vinorelbine, and Thiotepa (TVTC) in Children and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in P... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • FDA Approves Tecvayli at Reduced Dosing Frequency for Relapsed/Refractory Multiple Myeloma
    FDA Approves Tecvayli at Reduced Dosing Frequency for Relapsed/Refractory Multiple MyelomaFebruary 24th, 2024
  • Janssen Presents Longer-Term Data for TECVAYLI® (Teclistamab-Cqyv) Showing a Duration of Response of 22 Months in Patients with Relapsed or Refractory Multiple Myeloma
    Janssen Presents Longer-Term Data for TECVAYLI® (Teclistamab-Cqyv) Showing a Duration of Response of 22 Months in Patients with Relapsed or Refractory Multiple MyelomaJune 10th, 2023
  • FDA Approves Biweekly Teclistamab Dosing Regimen for Patients with Multiple Myeloma
    FDA Approves Biweekly Teclistamab Dosing Regimen for Patients with Multiple MyelomaFebruary 22nd, 2024

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Oklahoma BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Rachel Kobos, Dr. Rachel Kobos, MD, Dr. R Kobos